Breast Cancer News and Research

Latest Breast Cancer News and Research

SBI urges Congress to exclude the USPSTF guidelines from health care legislation

Several sections of Senate health care reform legislation contain language stipulating that insurance entities such as private insurers, Medicare and Medicaid would only be required to cover services receiving a specific grade from the U.S. Preventative Services Task Force. Presently, this would exclude mammography services for women 40-49, would only require coverage of biennial (every other year) coverage for women 50-74, and exclude coverage for those 74 and older.

25 Nov 2009

Alpha-fetoprotein, a well-tolerated agent for treatment and prevention of breast cancer

Researchers have found that hormones produced during pregnancy induce a protein that directly inhibits the growth of breast cancer. This protein, alpha-fetoprotein (AFP), may serve as a viable, well-tolerated agent for the treatment and prevention of breast cancer, according to findings published in Cancer Prevention Research, a journal of the American Association for Cancer Research.

25 Nov 2009

Initiation of Phase II clinical trial to evaluate the efficacy of BN83495 announced

Ipsen today announced the initiation of an international, multi-center, controlled, randomized Phase II clinical trial to evaluate the safety and efficacy of BN83495, its investigational first-in-class steroid sulfatase (STS) inhibitor, in advanced endometrial cancer.

25 Nov 2009

Guardian Life Insurance Company of America continues its present coverage guidelines for mammography screenings

The Guardian Life Insurance Company of America (Guardian), one of the largest mutual life insurers and a leading provider of employee benefits for small and mid-sized companies, today announced that the company will continue to follow its current insurance coverage guidelines for mammography screenings.

25 Nov 2009

New mammography guidelines can set breast health care back a half century in time, says cancer expert

Until recently, women hitting their 40th birthdays expected to begin receiving yearly mammograms to screen for breast cancer. Earlier this week, the U.S. Preventive Services Task Force (USPSTF), a government appointed task force, advised cutting back on the number of mammograms that women receive, as well as pushing back the age of the first mammogram to 50.

25 Nov 2009

Enzyme that plays an important role in the formation of breast tumours identified

A team of US scientists found that the enzyme lysyl oxidase (LOX) alters the structure of collagen - the major component of connective tissue - in the cells surrounding the growing tumour.

25 Nov 2009

Guardian Technologies' novel imaging analysis technology platforms may help avoid mammography false positives

Guardian Technologies International, Inc. -- A recent U.S. Preventive Services Task Force report suggests that while mammograms save lives, they also lead to unnecessary additional procedures. Experts suggest that the problem with mammography is that improvements are needed to reduce false positives and increase accuracy.

24 Nov 2009

Poll: Women in their 40's will still get mammograms, despite new guidelines

USA Today reports that "[a] vast majority of American women plan to ignore controversial new recommendations about mammograms, a USA TODAY/Gallup Poll shows. The poll also shows that most women sharply overestimate their risk of developing the disease."

24 Nov 2009

Innovation Award for GMI presented at the 2009 World Congress on Medical Physics

Gamma Medica-Ideas, Inc., a leading developer of digital molecular imaging systems, announced today that it has been awarded an Innovation Award for its new prototype imaging system that combines the molecular imaging (MI) capability of single-photon nuclear imaging with magnetic resonance imaging (MRI). The award was presented to GMI at the 2009 World Congress on Medical Physics and Biomedical Engineering in Munich, Germany that took place on September 7th, 2009.

24 Nov 2009

Breast cancer patients treated with chemotherapy drug Taxol more likely to develop chronic neuropathic pain

Breast cancer patients treated with the chemotherapy drug Taxol (paclitaxel) are more likely to develop chronic neuropathic pain, according to research published in The Journal of Pain, the peer review publication of the American Pain Society.

24 Nov 2009

LCA-NY issues 2009 Report Card on Lung Cancer

Today, Lung Cancer Alliance-New York (LCA-NY) issued its 1st Report Card on Lung Cancer. This Report is an assessment of progress being made against lung cancer in the state of New York. LCA-NY is a chapter of Lung Cancer Alliance (LCA), the only national organization dedicated exclusively to patient support and advocacy for people living with or at risk for lung cancer.

23 Nov 2009

Guideline controversy: 'Politics is always intruding into the world of breast cancer'

Kaiser Health News' Peggy Girshman talks with Dr. Barron Lerner about the politics surrounding the recent release of mammography guidelines.

23 Nov 2009

Administration seeks to distance reform effort from cancer screening fallout

As the intense debate continues over new cancer test guidelines, the Obama administration is trying to protect health care reform from the controversy's fallout.

23 Nov 2009

AdnaTest BreastCancer Select & Detect kit now available in the Czech Republic and Slovakia

OncoVista Innovative Therapies, Inc., reported that the AdnaTest BreastCancer Select & Detect kit, manufactured by AdnaGen AG (Langenhagen, Germany), is now available for research as well as for pay-out-of-pocket patients in the Czech Republic and Slovakia.

23 Nov 2009

Provectus Pharmaceuticals announces Phase 1 interim study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that initial one year overall survival data from the first 20 subjects in the current Phase 2 trial showed comparable trends to Phase 1 survival data.

23 Nov 2009

First Edition: November 23, 2009

Today's headlines indicate that even after Senate Majority Leader Harry Reid found victory Saturday night with the first health bill test vote, his measure is likely to be the subject of an even more intense debate as the measure moves forward.

23 Nov 2009

Editorial provides guidance for media and journals to help foster healthy skepticism in news coverage

An editorial published online November 20 in the Journal of the National Cancer Institute discusses the exaggerated fears and hopes that often appear in news coverage of cancer research. The editorial provides guidance for both the media and journals to help alleviate the problem.

21 Nov 2009

Cancer promoting gene identified

Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. Scientists hope the finding could lead to an effective therapy to target and inhibit the expression of this gene resulting in inhibition of cancer growth.

21 Nov 2009

Program on patients undergoing individualized treatment for metastatic breast cancer: NCCN

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers, has collaborated with the Discovery Health Channel to produce a program profiling three patients with metastatic breast cancer and their healthcare team as they customize each patient's treatment regimen to their individual tumor type and health status.

21 Nov 2009

Obesity: A major contributor to the development of Type 2 diabetes

"Many Americans have a very limited understanding of the basic facts about diabetes, as well as the serious consequences for health that accompany the disease," commented Sue McLaughlin, RD, CDE, President, Health Care & Education, American Diabetes Association, in a media alert. She blames the problem on a combination of factors including denial of the disease and promotion of inaccurate information or myths surrounding diabetes.

21 Nov 2009

Breast Cancer News and Research

Latest Breast Cancer News and Research

SBI urges Congress to exclude the USPSTF guidelines from health care legislation

Alpha-fetoprotein, a well-tolerated agent for treatment and prevention of breast cancer

Initiation of Phase II clinical trial to evaluate the efficacy of BN83495 announced

Guardian Life Insurance Company of America continues its present coverage guidelines for mammography screenings

New mammography guidelines can set breast health care back a half century in time, says cancer expert

Enzyme that plays an important role in the formation of breast tumours identified

Guardian Technologies' novel imaging analysis technology platforms may help avoid mammography false positives

Poll: Women in their 40's will still get mammograms, despite new guidelines

Innovation Award for GMI presented at the 2009 World Congress on Medical Physics

Breast cancer patients treated with chemotherapy drug Taxol more likely to develop chronic neuropathic pain

LCA-NY issues 2009 Report Card on Lung Cancer

Guideline controversy: 'Politics is always intruding into the world of breast cancer'

Administration seeks to distance reform effort from cancer screening fallout

AdnaTest BreastCancer Select & Detect kit now available in the Czech Republic and Slovakia

Provectus Pharmaceuticals announces Phase 1 interim study data of PV-10 for metastatic melanoma

First Edition: November 23, 2009

Editorial provides guidance for media and journals to help foster healthy skepticism in news coverage

Cancer promoting gene identified

Program on patients undergoing individualized treatment for metastatic breast cancer: NCCN

Obesity: A major contributor to the development of Type 2 diabetes

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Breast Cancer News and Research

Latest Breast Cancer News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in